checkAd

    EQS-News  137  0 Kommentare Gerresheimer expands capacities for Medical Systems in the USA

    Für Sie zusammengefasst
    • Gerresheimer expands capacities in the USA
    • Investment of USD 180 million for new buildings
    • Creation of over 400 new jobs in Peachtree City

    EQS-News: Gerresheimer AG / Key word(s): Expansion
    Gerresheimer expands capacities for Medical Systems in the USA

    27.05.2024 / 13:00 CET/CEST
    The issuer is solely responsible for the content of this announcement.


    Gerresheimer expands capacities for Medical Systems in the USA

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Gerresheimer AG!
    Long
    87,08€
    Basispreis
    1,26
    Ask
    × 7,99
    Hebel
    Short
    112,54€
    Basispreis
    1,47
    Ask
    × 6,83
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    • Two-stage expansion of the Peachtree City, Georgia site
    • Total investment volume of around USD 180 million
    • More than 400 new jobs for skilled workers from the region
    • Ramp-up of production beginning end of 2024

    Düsseldorf / Peachtree City, USA, May 27, 2024 – Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, is significantly expanding its production capacities for medical systems such as inhalers and autoinjectors in the United States. In two expansion stages, Gerresheimer is expanding the production area at its Peachtree City site in the state of Georgia, USA, by around 18,000 m² (194,000 sqft). The company is investing a total of around 166 million euros (USD 180 million) in the construction and equipping of the two new buildings. Gerresheimer will create more than 400 new jobs in Peachtree City as part of the expansion. The company currently employs around 270 people at the site. With the expansion in Peachtree, Gerresheimer is also underscoring its leading market position as a system and solution provider for drug delivery systems in the North American market.

     "North America is an important growth market for us. The expansion of the site in Peachtree City is of great importance for our medical device business in the USA," says Dietmar Siemssen, CEO of Gerresheimer AG. "The expansion of this site is therefore currently one of the key projects in our global capacity expansions based on long-term customer contracts."

    Construction work of the first expansion stage almost completed 

    In the first stage of expansion, a new building section covering around 7,700 m² (83,000 sqft) was built directly next to the existing plant. Around 5,000 m² (53,800 sqft) are intended for ISO 14644-1 cleanroom class 9 production areas. After completion of the construction work, the installation of the specialized production technology will begin in the second half of 2024. At the end of 2024, ramp-up of production will start in the new section of the building. Also part of the new building is a new, automated high-bay warehouse. After completion of the first stage of expansion, the Peachtree City site will have a total of approximately 12,000 m² (130,000 sqft) of cleanroom class 8 and 9 production space.

    Seite 1 von 4


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-News Gerresheimer expands capacities for Medical Systems in the USA EQS-News: Gerresheimer AG / Key word(s): Expansion Gerresheimer expands capacities for Medical Systems in the USA 27.05.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. Gerresheimer expands capacities …

    Schreibe Deinen Kommentar

    Disclaimer